Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan 11;6(1):11.
doi: 10.1038/s41392-020-00439-6.

Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein

Anshumali Mittal  1 , Vikash Verma  2
Affiliations
Comment

Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein

Anshumali Mittal et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The structure and infectivity of the wild-type (D614) and mutant (D614G) spike proteins. a An illustration of SARS-CoV-2 infecting human lungs. b Cryo-EM structure of the spike proteins (PDB: 6vsb and 6xs6), the black circle in the center indicates the position of the amino acid D614 and/or D614G. The structures of the wild-type (cyan) and mutant (red) spike proteins were superimposed, which show an overall similar architecture between them with an rmsd of 0.77 Å. The first inset (upper panel) shows residues D614 in cyan and D614G in red. The second inset (lower panel) shows residue D614 forming an H-bond with T859 of the adjacent protomer in the wild-type spike protein (PDB: 6vsb). The D614G mutation causes an increase in the distance between D614G and T859, which results in elimination of the H-bond formation between them (PDB: 6XS6). c An illustration of mutant SARS-CoV-2 infecting human lungs. d The D614G spike trimer is comparatively more flexible and adopts at least four major conformations in contrast to two observed for the D614 protein trimer. The D614G mutation causes spike protein trimer to occupy more open conformations, which increases the probability of ACE2 receptor binding and the virion membrane-target cell fusion. Circles in light green indicate close conformation of the protomer and illustrations of Pac-Man in the dark green indicate open conformation of the protomer. The figures were prepared using Pymol and Adobe Illustrator
See this image and copyright information in PMC

Comment on

  • Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
    Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J. Yurkovetskiy L, et al. Cell. 2020 Oct 29;183(3):739-751.e8. doi: 10.1016/j.cell.2020.09.032. Epub 2020 Sep 15. Cell. 2020. PMID: 32991842 Free PMC article.

References

    1. Yurkovetskiy L, et al. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell. 2020;183:739–751.e738. doi: 10.1016/j.cell.2020.09.032. - DOI - PMC - PubMed
    1. Mittal A, et al. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2. PLoS Pathog. 2020;16:e1008762. doi: 10.1371/journal.ppat.1008762. - DOI - PMC - PubMed
    1. Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e278. doi: 10.1016/j.cell.2020.02.052. - DOI - PMC - PubMed
    1. Korber B, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812–827.e819. doi: 10.1016/j.cell.2020.06.043. - DOI - PMC - PubMed
    1. Walls AC, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281–292.e286. doi: 10.1016/j.cell.2020.02.058. - DOI - PMC - PubMed

Substances